Immunomodulation using placental stem cells

Details for Australian Patent Application No. 2006304277 (hide)

Owner Anthrogenesis Corporation

Inventors Edinger, James; Murray, RoseAnn; Paludan, Casper; Harbacheuski, Ryhor; Hariri, Robert J.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2006304277

PCT Pub. Number WO2007/047468

Priority 60/727,004 13.10.05 US; 60/835,628 04.08.06 US

Filing date 13 October 2006

Wipo publication date 26 April 2007

Acceptance publication date 5 July 2012

International Classifications

C12N 5/00 Undifferentiated human, animal or plant cells, e.g. cell lines

A61K 35/50 Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61P 37/06 Drugs for immunological or allergic disorders

C12N 5/073 Undifferentiated human, animal or plant cells, e.g. cell lines - Embryonic cells or tissues

Event Publications

1 May 2008 PCT application entered the National Phase

  PCT publication WO2007/047468 Priority application(s): WO2007/047468

5 July 2012 Application Accepted

  Published as AU-B-2006304277

1 November 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006304283-Biphenyl derivatives as modulators of voltage gated ion channels

2006304276-Cable and crimp for bone surgery